PFIZER INC — Director's Dealing 2023

Mar 21, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pyxis Oncology, Inc. (PYXS)
CIK: 0001782223
Period of Report: 2023-03-17

Reporting Person: PFIZER INC (10% Owner)
Reporting Person: Pfizer Ventures (US) LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-17	Common Stock, $0.001 par value per share	P	1811594	$2.76	Acquired	5952263	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.001 par value per share	1080507	Indirect

Footnotes

F1: The shares are owned directly by Pfizer Ventures (US) LLC, which is a wholly owned subsidiary of Pfizer Inc.